Muscle-Saving combo tested alongside popular Weight-Loss meds

NCT ID NCT06885736

First seen Mar 28, 2026 · Last updated Jun 22, 2026 · Updated 12 times

Summary

This study tests whether resistance exercise and extra protein can help preserve muscle mass in people starting weight-loss drugs like semaglutide or tirzepatide. 232 adults with obesity will be randomly assigned to one of four groups: control, extra protein, exercise, or both. The goal is to see if these strategies prevent muscle loss and improve physical function over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dasman Diabetes Institute

    RECRUITING

    Kuwait City, Kuwait

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

resistance exercise and increased protein intake

What this could lead to

If it works, this could show a way to prevent muscle loss while taking weight-loss drugs, leading to healthier weight loss.

What could go wrong

This is a relatively small, early-stage study without a drug approval phase. Results may not apply to everyone, and sticking to exercise and diet changes can be hard.

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.